ConductScience.org, home

Paper17285752

Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.

Malhotra M and 1 other. AAPS PharmSciTech, 2006. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note. Papers, record 17285752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17285752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.
PubMed
Journal
AAPS PharmSciTech
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2019-05-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Malhotra MManjusha
2Majumdar DKDipak K

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DinoprostoneMajor topic
Drug CompoundingMajor topic
ExcipientsMajor topic
KetorolacMajor topic
OsteitisMajor topic
Administration, Topical
Animals
Female
Male
Oils
Ointments
Rabbits
Treatment Outcome
Water

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14361492Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin.Invest Ophthalmol1973https://conductscience.org/library/papers/4361492PubMed
2338326Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier.Exp Eye Res1977https://conductscience.org/library/papers/338326PubMed
3272840Inflammatory responses of the rabbit eye to prostaglandins.Agents Actions Suppl1977https://conductscience.org/library/papers/272840PubMed
47409999The role of arachidonic acid metabolites in the mediation of the polymorphonuclear leukocyte response following corneal injury.Invest Ophthalmol Vis Sci1980https://conductscience.org/library/papers/7409999PubMed
57243231Antiproteolytic activities found in human tears.Ophthalmology1981https://conductscience.org/library/papers/7243231PubMed
616354013In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.AAPS PharmSciTech2005https://conductscience.org/library/papers/16354013PubMed
73980167Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity.Invest Ophthalmol Vis Sci1985https://conductscience.org/library/papers/3980167PubMed
86984594The analgesic and anti-inflammatory profile of (+/-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619).Agents Actions1982https://conductscience.org/library/papers/6984594PubMed
93355415The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.Arch Ophthalmol1988https://conductscience.org/library/papers/3355415PubMed
103262701Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.J Ocul Pharmacol1988https://conductscience.org/library/papers/3262701PubMed
113141537Topical arachidonic acid: a model for screening anti-inflammatory agents.J Ocul Pharmacol1987https://conductscience.org/library/papers/3141537PubMed
129315239Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil.Indian J Exp Biol1997https://conductscience.org/library/papers/9315239PubMed
139567769In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.Indian J Exp Biol1997https://conductscience.org/library/papers/9567769PubMed
149826736Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9826736PubMed
1510088733Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.Am J Ophthalmol1999https://conductscience.org/library/papers/10088733PubMed
1711934202Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebo-controlled trial.J Refract Surg2002https://conductscience.org/library/papers/11934202PubMed
1811158809Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.Ophthalmology2001https://conductscience.org/library/papers/11158809PubMed
194638977Prostaglandin E 1 and aqueous humor dynamics.Invest Ophthalmol1972https://conductscience.org/library/papers/4638977PubMed
2012622201Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.Indian J Exp Biol2002https://conductscience.org/library/papers/12622201PubMed
213492994Effect of ketorolac on Candida albicans ocular infection in rabbits.Arch Ophthalmol1987https://conductscience.org/library/papers/3492994PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
38888757Recent updates on ocular disease management with ophthalmic ointments.Ther Deliv2024https://conductscience.org/library/papers/38888757PubMed
28884078Effects of topical flurbiprofen sodium, diclofenac sodium, ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs.Open Vet J2017https://conductscience.org/library/papers/28884078PubMed
21979886Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.AAPS PharmSciTech2011https://conductscience.org/library/papers/21979886PubMed
18437583Topical ocular delivery of NSAIDs.AAPS J2008https://conductscience.org/library/papers/18437583PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17285752

GET https://conductscience.org/api/papers/v1/17285752/authors